mRNA-Based Therapeutics Summit Europe

Built with biopharmaceutical industry insights, this in-person conference will bring together key opinion leaders from Europe and the rest of the world to delve deep into the challenges associated with successfully designing and developing the next-generation of mRNA-based vaccines & therapeutics with improved specificity, delivery & efficacy for immuno-oncology, infectious diseases and beyond.

With 20+ pioneering large pharma, biotech and academic experts who are shaping the landscape of mRNA- based therapeutics for the scientific community world-wide, hear how they address the major challenges facing the industry.

Optimise the Efficacy, Cell- & Tissue- Specificity & Translatability of Your mRNA- Based Pipeline
With the limitless opportunity of mRNA- based Therapeutics across different modalities, consider the challenges of efficacy and improve cell- & tissue- specificity with expert insights from Professor Drew Weissman, Strand Therapeutics & Chalmers University of Technology

Explore Applications of mRNA- Based Therapeutics Beyond Infectious Diseases
From immune-oncology to rare and autoimmune diseases, dive into emerging applications and potential challenges of mRNA- based vaccines and therapeutics beyond infectious diseases with case studies from Moderna, BioNTech & Ethris

Navigate New & Emerging Delivery Technologies for mRNA- Based Therapeutics
Take yourself to the forefront of mRNA delivery system development, from structure through to administration with insights from BioNTech, Johnson & Johnson & Med Therapeutics

Strategise Your Scalable & Global mRNA-Based Vaccine Development
With the global outreach of mRNA- based vaccines, scalability is a major hurdle. Hear the latest technological advances and regulatory standards in mRNA- based vaccine and therapeutic landscape from Sanofi, Ziphius Vaccines & Arcturus Therapeutics

Tune into How Companies are Differentiating Their Pipelines Beyond mRNA- Based Vaccines
With the success of mRNA- based vaccines fulfilling novel technologies and therapies such as mRNA- based protein replacement, hear from companies like Strand Therapeutics, Turn Biotechnologies & Orna Therapeutics on the emerging strategies that will enable innovation in the field

Take advantage of our group discounts, academic rates and earlybird savings - don't miss out register now for the best rate!